Mersana Therapeutics Overview
Mersana Therapeutics Discounted Cash Flow
DCF Analysis for MRSN.
Get informed when a big investor buys or sells
+ FollowFair Value
$-1.14
Current Fair Value
$-1.14
↓ 103.9% Downside
Overvalued by 103.9% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison